NCT05060848View on ClinicalTrials.gov

Plasma Hydrogen Sulfide as a Biomarker for Alzheimer's Disease and Related Dementias

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
Alzheimer DiseaseDementia
Trial Locations (1)

71103

LSU Health Shreveport Center for Brain Health, Shreveport

All Listed Sponsors
lead

Louisiana State University Health Sciences Center Shreveport

OTHER